Identification of Novel Transcriptional Regulators of Stem Cell Derived Cardiomyocyte Maturation
Identification of Novel Transcriptional Regulators of Stem Cell Derived Cardiomyocyte Maturation
批准号:
9906423
负责人:
Elaheh Karbassi
金额:
$6.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2023-02-28
关键词:
Action PotentialsAdultAgingAnimal ModelAnimalsAreaArrhythmiaBinding SitesBiogenesisBypassCRISPR screenCalciumCandidate Disease GeneCardiacCardiac MyocytesCell TherapyCellsChIP-seqChromatinChromatin StructureClinicClustered Regularly Interspaced Short Palindromic RepeatsCulture MediaDNADataData SetDevelopmentDiseaseDisease modelElectrophysiology (science)EmbryoEnergy-Generating ResourcesEngraftmentEpigenetic ProcessExpression ProfilingFosteringFutureGene ExpressionGenesGenetic TranscriptionGenomeGenomicsGlucoseGoalsHeartHumanHuman bodyIn VitroInfarctionInjectionsInjuryLeadLengthMeasuresMembrane PotentialsMitochondriaMyocardial InfarctionMyofibrilsNatural regenerationOrganPacemakersPatientsPatternPhenotypePotassium ChannelPropertyProtein IsoformsProtocols documentationPublishingRattusRegulationRegulator GenesReperfusion InjuryResearchResearch PersonnelResearch Project GrantsResearch TrainingRestSarcomeresSiteSodium ChannelStructural GenesStructureSystemTestingTherapeuticTimeTissue-Specific Gene ExpressionTissuesTranslationsTransplantationUp-RegulationXCL1 genebasecombinatorialfatty acid oxidationfetus cellfollow up assessmentgain of functiongenetic testingheart damageheart functionhuman embryonic stem cellhuman pluripotent stem cellhuman stem cellsin vivoinduced pluripotent stem cellnonhuman primatenovelnovel strategiespost-transplantprogramsregenerativescreeningsingle-cell RNA sequencingstem cellstranscription factortranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
The purpose of this research project is to mature human pluripotent stem cell-derived cardiomyocytes (hiPSC-
CMs) via transcriptional programming, such that they display adult-like electrophysiological properties. hPSC-
CM applications for cell therapy and disease modeling are limited due to the cells’ lack of resemblance
structurally and functionally to their adult counterparts. The development of arrhythmias has been a major
problem after transplantation of hPSC-CMs into non-human primates and thus presents a major obstacle in the
translation of hPSC-CMs to the clinic. I hypothesize that the immature state of hPSC-CMs is a major contributor
to the graft-induced arrhythmias, and transcriptional programming of these cells will be an effective system to
enhance the maturation state of hPSC-CMs in vitro for various applications. The specific aims for this project
are: 1) to identify a core set of cardiac transcriptional regulators that can be used to combinatorially program
hiPSC-CM electrical maturation and induce adult-like cardiac electrophysiological properties, and 2) to elucidate
the chromatin structural mechanisms by which maturation transcriptional regulators coordinate differential gene
expression. We have identified candidate transcriptional regulators by studying human cardiomyocyte
maturation in vivo after transplantation. We will activate these regulators using CRISPR activation (CRISPRa) to
test their sufficiency in generating electrically mature cardiomyocytes. Maturation will be measured by single cell
RNA-sequencing analyses and follow-up assessment of electrophysiological properties. Next, chromatin
immunoprecipitation-sequencing will be performed to identify candidate transcription factor target genomic
binding sites. ATAC-sequencing will be used to assess regulation of genome accessibility in programmed hiPSC-
CMs and to characterize the epigenetic mechanisms by which top candidate factors fully and/or partially program
maturation gene expression. This project presents a new approach to mature hiPSC-CMs by using high
throughput and combinatorial CRISPR-based screening and will provide characterization of chromatin structural
features regulating cardiomyocyte maturation. Through generating more mature hiPSC-CMs, these programmed
cardiomyocytes can be applied as cell therapy to remuscularize damaged heart tissue in patients after
myocardial infarction, while bypassing graft-induced arrhythmias. This project will build on the applicant’s
research training and skillsets and will serve to foster the applicant’s path towards becoming an independent
investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Novel Transcriptional Regulators of Stem Cell Derived Cardiomyocyte Maturation
-
批准号:10321528
-
项目类别:
-
资助金额:$7.05万
-
财政年份:2020
-
负责人:Elaheh Karbassi
-
依托单位:
海外基金